Companies Cryptocurrencies
Seres Therapeutics Inc
Seres Therapeutics Inc
Exchange: Nasdaq Global Select
IPO Date: 26/06/2015
CEO: Mr. Eric Shaff
Biotechnology Healthcare 🔗
  • MCRB
  • price
  • market cap
  • changes
If you bought

shares of Seres Therapeutics Inc (MCRB) on
You would have made
Old Price $12 Current Price $12

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. The company is headquartered in Cambridge, Massachusetts and currently employs 145 full-time employees. The firm is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The firm’s drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The firm is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The firm is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.

Address: 200 Sidney St Cambridge MASSACHUSETTS 02139

Stay updated.